Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After G-POEM
Primary Purpose
Gastroparesis
Status
Completed
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
Closure of mucosotomy using endoscopic clips
Closure of mucosotomy using OverStitch™ suturing device
Sponsored by
About this trial
This is an interventional treatment trial for Gastroparesis focused on measuring Gastric Per-oral Endoscopic Pyloromyotomy
Eligibility Criteria
Inclusion Criteria:
Refractory (> 6 months) and severe (based on a validated total Gastroparesis Cardinal Symptom Index) gastroparesis, with confirmed gastric emptying based on a gastric emptying study: standardized protocol of scintigraphy in all patients (performed less than 6 months prior to enrolment). The total GSCI (Gastroparesis Cardinal Symptom Index) score must be >2.0
- Abnormal gastric emptying is defined as retention of Tc-99 m >60% at 2 h and/or ≥10% of residual activity at 4 h on a standardized sulphur colloid solid-phase gastric emptying study.
- Abnormal gastric emptying breath test based on a solid normal range determination for the test used (e.g. T1/2 > 109 min)
- Severe refractory disease is defined as GCSI >2.0 and failure or recurrence in patients who received available optimal pharmacological therapies.
- Persons 18 years or older at the time of signing the informed consent
- Signed informed consent
Exclusion Criteria:
- No previous attempt with at least one prokinetic drug
- No previous attempt to withdraw anticholinergic agents and glucagon like peptide -1 (GLP-1) and amylin analogues in patients treated with these substances
- Active treatment with opioids or a history of treatment with opioids within 12 months before enrolment
- Previous gastric surgery (Billroth I or Billroth II)
- Known eosinophilic gastroenteritis
- Organic pyloric (or intestinal) obstruction (fibrotic stricture, etc.)
- Sever coagulopathy
- Oesophageal or gastric varices and /or portal gastropathy
- Advanced liver cirrhosis (Child B or Child C)
- Active peptic ulcer disease
- Pregnancy or puerperium
- Malignant or pre-malignant gastric diseases (dysplasia, gastric cancer, GIST): patients with a history of such disease after its cure are eligible for enrolment
- Any other condition, which in the opinion of the investigator would interfere with study requirements
- Uncontrolled diabetes mellitus
- Diagnosis of rumination syndrome or "eating" disorder (mental anorexia, bulimia nervosa)
- Inability to obtain informed consent
Sites / Locations
- Institute for Clinical and Experimental Medicine
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Endoscopic clips
OverStitch™ suturing device
Arm Description
Closure of mucosotomy using endoscopic clips
Closure of mucosotomy using OverStitch™ suturing device
Outcomes
Primary Outcome Measures
Proportion of subjects with successful and safe incision closure.
Definition of successful closure: endoscopically completely closed incision, no need to use another "rescue" closure method, no leak on post-operative day 1, no leak related complications, no readmission due to closure dehiscence, no need for surgery due to closure.
Secondary Outcome Measures
Easiness of the closure
Handling with endoclips or OverStitch will be evaluated by means of a questionnaire where ease of use was scored on a VAS (visual analogue scale), 0 = impossible, 10 = very easy) by both, endoscopist as well as an endoscopy nurse assisting with the closure procedure.
Closure time of mucosotomy
The duration of endoscopic closure, reported by the endoscopist performing the procedure
Cost
To evaluate the economics and cost-effectiveness of treating gastroparesis
Healing quality
Assessing gastric scar after gastric per-oral pyloromyotomy: based on a visual examination, the healing process could include three stages, namely stage A (active stage): means no tissue reparation features, stage H (healing stage): early morphological reparation features, and stage S (scar stage): completed repair process, that could by described as S1 (red) or S2 (white). Width and length of scar will be measures as well.
Readmission within 30 days
A readmission for an endoscopic or surgery intervention to address a complication resulting from care during the initial admission.
Mortality at 3 months
Incidence of fatal complications related to procedure
Full Information
NCT ID
NCT03679104
First Posted
August 12, 2018
Last Updated
January 26, 2021
Sponsor
Institute for Clinical and Experimental Medicine
1. Study Identification
Unique Protocol Identification Number
NCT03679104
Brief Title
Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After G-POEM
Official Title
Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After Per-oral Endoscopic Pyloromyotomy (G-POEM)
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
November 1, 2018 (Actual)
Primary Completion Date
December 1, 2020 (Actual)
Study Completion Date
January 26, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Institute for Clinical and Experimental Medicine
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Gastric per-oral endoscopic pyloromyotomy (G-POEM) has been assessed as new modality for treatment of refractory gastroparesis. G-POEM is promising method, which is still under investigation as its safety and efficacy has not been established yet. The ideal closure technique in patients undergoing G-POEM needs to be established. Several techniques may be used for endoscopic mucosal closure: endoscopic clips, OTSC (over the scope clips), endo-loop based methods (KING closure) or endoscopic suture.
The aim of this prospective, open-label study is to compare efficacy and safety of two methods for incision closure in patients who undergo G-POEM: endoscopic clips vs. endoscopic suturing system (OverStitch).
Detailed Description
Based on principles of NOTES (natural orifice transluminal endoscopic surgery), a mini-invasive therapeutic procedure such as per-oral endoscopic myotomy (POEM) or gastric per-oral endoscopic pyloromyotomy (G-POEM) have been assessed as new modalities for treatment of oesophageal achalasia or refractory gastroparesis. G-POEM is a new and promising method, which is still under investigation as its safety and efficacy has not been established yet. There are several questions, which need to be answered before G-POEM is considered as a standard clinical procedure. These questions concern, among others, efficacy, safety, technical performance etc. Mucosal incision should be endoscopically closed to prevent leakage into the abdominal cavity. Obtaining adequate mucosal closure is one of the most important steps of the procedure and is essential in avoiding major morbidity. The ideal closure technique in patients undergoing G-POEM needs to be established. Several techniques may be used for endoscopic mucosal closure: endoscopic clips, OTSC clips, endo-loop based methods (KING closure) or endoscopic suture. At present, simple closure with endoscopic clips has been the most frequently described method for mucosal closure in patients undergoing G-POEM. However, as gastric mucosa is thicker compared to the esophagus, where clips are used for POEM without any major problems, several authors have described problems during gastric incision closure - it takes a rather longer time, some clips cannot be placed and in some patients, other closure method had to be used. Thus, endoscopic clips may not be an ideal closure method in the stomach. A platform that replicates a principle of surgical suturing is endoscopic suturing system.
The aim of this prospective, open-label study is to compare efficacy and safety of two methods for incision closure in patients who undergo G-POEM: endoscopic clips vs. endoscopic suturing system (OverStitch).
Investigators plan to randomize 30-40 patients (15-20 in both arms, ratio 1:1).
The assigned closure method will be decided by an endoscopist prior to starting closure.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastroparesis
Keywords
Gastric Per-oral Endoscopic Pyloromyotomy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Patients will be allocated to the corresponding group according to a peri-procedural finding, availability of a respective closure method and endoscopist´s decision.
Masking
Investigator
Allocation
Randomized
Enrollment
40 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Endoscopic clips
Arm Type
Active Comparator
Arm Description
Closure of mucosotomy using endoscopic clips
Arm Title
OverStitch™ suturing device
Arm Type
Active Comparator
Arm Description
Closure of mucosotomy using OverStitch™ suturing device
Intervention Type
Procedure
Intervention Name(s)
Closure of mucosotomy using endoscopic clips
Intervention Description
Gastric per-oral endoscopic pyloromyotomy procedure requires the incision in the mucosa and submucosa. The closure of this incision at the end of the procedure will be done using endoscopic clips. These are used in endoscopy to mechanically close two mucosal surfaces without the need for surgery and suturing. In this study, the following endoclips may be used: Resolution 360™ Clip (Boston Scientific), QuickClip Pro™(Olympus) or Instinct™ Endoscopic Hemoclip (Cook Medical).
Intervention Type
Procedure
Intervention Name(s)
Closure of mucosotomy using OverStitch™ suturing device
Intervention Description
Gastric per-oral endoscopic pyloromyotomy procedure requires the incision in the mucosa and submucosa. The closure of this incision at the end of the procedure will be done by OverStitch™ (Apollo Endosurgery Inc., Austin, Texas, USA), which is a suturing device that enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope.
Primary Outcome Measure Information:
Title
Proportion of subjects with successful and safe incision closure.
Description
Definition of successful closure: endoscopically completely closed incision, no need to use another "rescue" closure method, no leak on post-operative day 1, no leak related complications, no readmission due to closure dehiscence, no need for surgery due to closure.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Easiness of the closure
Description
Handling with endoclips or OverStitch will be evaluated by means of a questionnaire where ease of use was scored on a VAS (visual analogue scale), 0 = impossible, 10 = very easy) by both, endoscopist as well as an endoscopy nurse assisting with the closure procedure.
Time Frame
3 months
Title
Closure time of mucosotomy
Description
The duration of endoscopic closure, reported by the endoscopist performing the procedure
Time Frame
1 day
Title
Cost
Description
To evaluate the economics and cost-effectiveness of treating gastroparesis
Time Frame
3 months
Title
Healing quality
Description
Assessing gastric scar after gastric per-oral pyloromyotomy: based on a visual examination, the healing process could include three stages, namely stage A (active stage): means no tissue reparation features, stage H (healing stage): early morphological reparation features, and stage S (scar stage): completed repair process, that could by described as S1 (red) or S2 (white). Width and length of scar will be measures as well.
Time Frame
3 months
Title
Readmission within 30 days
Description
A readmission for an endoscopic or surgery intervention to address a complication resulting from care during the initial admission.
Time Frame
30 days
Title
Mortality at 3 months
Description
Incidence of fatal complications related to procedure
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Refractory (> 6 months) and severe (based on a validated total Gastroparesis Cardinal Symptom Index) gastroparesis, with confirmed gastric emptying based on a gastric emptying study: standardized protocol of scintigraphy in all patients (performed less than 6 months prior to enrolment). The total GSCI (Gastroparesis Cardinal Symptom Index) score must be >2.0
Abnormal gastric emptying is defined as retention of Tc-99 m >60% at 2 h and/or ≥10% of residual activity at 4 h on a standardized sulphur colloid solid-phase gastric emptying study.
Abnormal gastric emptying breath test based on a solid normal range determination for the test used (e.g. T1/2 > 109 min)
Severe refractory disease is defined as GCSI >2.0 and failure or recurrence in patients who received available optimal pharmacological therapies.
Persons 18 years or older at the time of signing the informed consent
Signed informed consent
Exclusion Criteria:
No previous attempt with at least one prokinetic drug
No previous attempt to withdraw anticholinergic agents and glucagon like peptide -1 (GLP-1) and amylin analogues in patients treated with these substances
Active treatment with opioids or a history of treatment with opioids within 12 months before enrolment
Previous gastric surgery (Billroth I or Billroth II)
Known eosinophilic gastroenteritis
Organic pyloric (or intestinal) obstruction (fibrotic stricture, etc.)
Sever coagulopathy
Oesophageal or gastric varices and /or portal gastropathy
Advanced liver cirrhosis (Child B or Child C)
Active peptic ulcer disease
Pregnancy or puerperium
Malignant or pre-malignant gastric diseases (dysplasia, gastric cancer, GIST): patients with a history of such disease after its cure are eligible for enrolment
Any other condition, which in the opinion of the investigator would interfere with study requirements
Uncontrolled diabetes mellitus
Diagnosis of rumination syndrome or "eating" disorder (mental anorexia, bulimia nervosa)
Inability to obtain informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jan Martinek
Organizational Affiliation
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Rastislav Hustak
Organizational Affiliation
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Zuzana Vackova
Organizational Affiliation
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Tomas Hucl
Organizational Affiliation
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jan Usak
Organizational Affiliation
Universitary hospital Trnava, Slovak Republic
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Julius Spicak, Prof
Organizational Affiliation
Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute for Clinical and Experimental Medicine
City
Prague 4
State/Province
Prague
ZIP/Postal Code
14021
Country
Czechia
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
27354102
Citation
Khashab MA, Ngamruengphong S, Carr-Locke D, Bapaye A, Benias PC, Serouya S, Dorwat S, Chaves DM, Artifon E, de Moura EG, Kumbhari V, Chavez YH, Bukhari M, Hajiyeva G, Ismail A, Chen YI, Chung H. Gastric per-oral endoscopic myotomy for refractory gastroparesis: results from the first multicenter study on endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017 Jan;85(1):123-128. doi: 10.1016/j.gie.2016.06.048. Epub 2016 Jun 25.
Results Reference
result
PubMed Identifier
28161449
Citation
Dacha S, Mekaroonkamol P, Li L, Shahnavaz N, Sakaria S, Keilin S, Willingham F, Christie J, Cai Q. Outcomes and quality-of-life assessment after gastric per-oral endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2017 Aug;86(2):282-289. doi: 10.1016/j.gie.2017.01.031. Epub 2017 Feb 1.
Results Reference
result
PubMed Identifier
25046348
Citation
Paspatis GA, Dumonceau JM, Barthet M, Meisner S, Repici A, Saunders BP, Vezakis A, Gonzalez JM, Turino SY, Tsiamoulos ZP, Fockens P, Hassan C. Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. 2014 Aug;46(8):693-711. doi: 10.1055/s-0034-1377531. Epub 2014 Jul 21.
Results Reference
result
PubMed Identifier
24332082
Citation
Kantsevoy SV, Bitner M, Mitrakov AA, Thuluvath PJ. Endoscopic suturing closure of large mucosal defects after endoscopic submucosal dissection is technically feasible, fast, and eliminates the need for hospitalization (with videos). Gastrointest Endosc. 2014 Mar;79(3):503-7. doi: 10.1016/j.gie.2013.10.051. Epub 2013 Dec 12.
Results Reference
result
PubMed Identifier
26954377
Citation
Crichton NJ. Principles of statistical analysis in nursing and healthcare research. Nurse Res. 2001 Oct 1;9(1):4-16. doi: 10.7748/nr2001.10.9.1.4.c6171.
Results Reference
result
Learn more about this trial
Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After G-POEM
We'll reach out to this number within 24 hrs